Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

The CASE-J trial enrolled 4728 patients, with a mean age of 63.8 years and a mean BMI of 24.6 kg/m 2, who were randomly assigned to either candesartan- or amlodipine-based treatment regimens.

300601.SZ Shenzhen Kangtai Biological Products Co., Ltd.

The 15 medicines included in the initiative include three branded medicines: valsartan for hypertension ... to treat heart failure and hypertension (amlodipine, bisoprolol, hydrochlorothiazide ...